166 related articles for article (PubMed ID: 32567076)
1. Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss.
Ramos PM; Gohad P; McCoy J; Wambier C; Goren A
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e24-e26. PubMed ID: 32567076
[No Abstract] [Full Text] [Related]
2. SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth.
Dhurat R; Daruwalla S; Pai S; Kovacevic M; McCoy J; Shapiro J; Sinclair R; Vano-Galvan S; Goren A
J Cosmet Dermatol; 2022 Jan; 21(1):343-346. PubMed ID: 34133836
[TBL] [Abstract][Full Text] [Related]
3. Minoxidil sulfotransferase enzymatical activity in plants: A novel paradigm in increasing minoxidil response in androgenetic alopecia.
Mehta N; Huang S; Dhura R; Wambier C; do Nascimento Fonesca D; Little S; Goren A
J Cosmet Dermatol; 2024 Jan; 23(1):339-343. PubMed ID: 37638619
[TBL] [Abstract][Full Text] [Related]
4. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia.
Goren A; Castano JA; McCoy J; Bermudez F; Lotti T
Dermatol Ther; 2014; 27(3):171-3. PubMed ID: 24283387
[TBL] [Abstract][Full Text] [Related]
5. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
Roberts J; Desai N; McCoy J; Goren A
Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
[TBL] [Abstract][Full Text] [Related]
6. Minoxidil: a comprehensive review.
Gupta AK; Talukder M; Venkataraman M; Bamimore MA
J Dermatolog Treat; 2022 Jun; 33(4):1896-1906. PubMed ID: 34159872
[TBL] [Abstract][Full Text] [Related]
7. Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent.
Chitalia J; Dhurat R; Goren A; McCoy J; Kovacevic M; Situm M; Naccarato T; Lotti T
Dermatol Ther; 2018 Nov; 31(6):e12688. PubMed ID: 30295395
[TBL] [Abstract][Full Text] [Related]
8. Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response.
Ramos PM; McCoy J; Wambier C; Shapiro J; Vañó-Galvan S; Sinclair R; Goren A
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):e799-e800. PubMed ID: 32432358
[No Abstract] [Full Text] [Related]
9. Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss.
McCoy J; Kovacevic M; Situm M; Stanimirovic A; Bolanca Z; Goren A
J Biol Regul Homeost Agents; 2016; 30(1):131-4. PubMed ID: 27049083
[TBL] [Abstract][Full Text] [Related]
10. Oral minoxidil bio-activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss.
Ramos PM; Goren A; Sinclair R; Miot HA
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):e40-e41. PubMed ID: 31420889
[No Abstract] [Full Text] [Related]
11. The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity.
Goren A; Mccoy J; Kovacevic M; Situm M; Chitalia J; Dhurat R; Naccarato T; Lotti T
J Biol Regul Homeost Agents; 2018; 32(4):937-940. PubMed ID: 30043580
[TBL] [Abstract][Full Text] [Related]
12. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
Sharma A; Goren A; Dhurat R; Agrawal S; Sinclair R; Trüeb RM; Vañó-Galván S; Chen G; Tan Y; Kovacevic M; Situm M; McCoy J
Dermatol Ther; 2019 May; 32(3):e12915. PubMed ID: 30974011
[TBL] [Abstract][Full Text] [Related]
13. Identification of the sulfotransferase iso-enzyme primarily responsible for the bio-activation of topical minoxidil.
McCoy J; Goren A; Naccarato T; Kovacevic M; Situm M; Skudar VL; Lotti T
J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):817-819. PubMed ID: 31184104
[TBL] [Abstract][Full Text] [Related]
14. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil treatment in Brazilian female pattern hair loss patients.
Ramos PM; Sinclair R; Miot HA; Goren A
Dermatol Ther; 2020 Jan; 33(1):e13195. PubMed ID: 31846181
[No Abstract] [Full Text] [Related]
15. Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients.
Goren A; Sharma A; Dhurat R; Shapiro J; Sinclair R; Situm M; Kovacevic M; Lukinovic Skudar V; Goldust M; Lotti T; McCoy J
Dermatol Ther; 2018 Nov; 31(6):e12741. PubMed ID: 30226287
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of 3% minoxidil vs. combined 3% minoxidil and Korean red ginseng in treating female pattern alopecia.
Ryu HJ; Yoo MG; Son SW
Int J Dermatol; 2014 Jun; 53(6):e340-2. PubMed ID: 24451023
[No Abstract] [Full Text] [Related]
17. Topical minoxidil for male pattern alopecia in two sets of twins.
Roenigk HH; Kuruvilla S
Cutis; 1987 Apr; 39(4):329. PubMed ID: 3581904
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
[TBL] [Abstract][Full Text] [Related]
19. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
20. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
Hoedemaker C; van Egmond S; Sinclair R
Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
